Phase 1 trial of CAR T-cell therapy likely to open soon to SSc patients
Adicet Bio expects adults with systemic sclerosis (SSc) soon to start enrolling in its ongoing Phase 1 clinical trial of ADI-001, an experimental CAR T-cell therapy that the company is developing for a number of autoimmune diseases. The company had expected sites to open to…